SQZ Biotechnologies Co
Healthcare · Biological Products, (No Diagnostic Substances) · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY22 | FY21 | FY20 | FY19 | |
|---|---|---|---|---|
| Revenue | $21.5M | $27.1M | $21.0M | $20.1M |
| Operating income | −$80.7M | −$68.8M | −$51.1M | −$34.3M |
| Net income | −$79.5M | −$68.7M | −$50.5M | −$32.2M |
| Total assets | $99.9M | $226.2M | $231.1M | $152.3M |
| Total liabilities | $42.8M | $102.2M | $103.9M | $93.8M |
| Equity | $57.1M | $124.0M | $127.2M | −$73.5M |
| EPS (diluted) | $-2.76 | $-2.49 | — | — |
| Shares out. | 28.1M | 27.9M | 24.8M | 1.7M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2022- Operating margin
- −375.7%
- Net margin
- −370.0%
- Return on equity
- −139.0%
- Return on assets
- −79.5%
- Return on capital (ROCE)
- −103.4%
- Liabilities / assets
- 42.8%
- Debt / equity
- 0.75×
- Book value / share
- $2.03
- Revenue growth (YoY)
- −20.7%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2022- Altman Z″ (distress)
- -9.95distress
- Accruals / assets
- 4.1%clean
- Piotroski F-Score
- 2/9weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 1 severe● 4 warning● 2 good- Altman Z″ in the distress zone
- Operating losses (negative operating margin)
- Reported a net loss
- Revenue declined year-over-year
- Negative operating cash flow
- Conservative leverage (liabilities < 50% of assets)
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Material events
SEC Form 8-K · most recent- Entered a material agreementDec 22, 2023
- Costs from exit or disposal · Material impairment · Director / officer changeOct 2, 2023
- Terminated a material agreementSep 15, 2023
- Other material eventJul 25, 2023
- Director / officer changeJul 7, 2023
- Delisting / listing-standard notice · Other material eventJul 3, 2023
- Delisting / listing-standard notice · Shareholder vote · Other material eventJun 15, 2023
- Director / officer changeApr 10, 2023
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.